Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;11(4):1554-1566.
doi: 10.21037/qims-20-444.

Meynert nucleus-related cortical thinning in Parkinson's disease with mild cognitive impairment

Affiliations

Meynert nucleus-related cortical thinning in Parkinson's disease with mild cognitive impairment

Siming Rong et al. Quant Imaging Med Surg. 2021 Apr.

Abstract

Background: Cognitive impairment in Parkinson's disease (PD) involves the cholinergic system and cholinergic neurons, especially the nucleus basalis of Meynert (NBM/Ch4) located in the basal forebrain (BF). We analyzed associations between NBM/Ch4 volume and cortical thickness to determine whether the NBM/Ch4-innervated neocortex shows parallel atrophy with the NBM/Ch4 as disease progresses in PD patients with cognitive impairment (PD-MCI).

Methods: We enrolled 35 PD-MCI patients, 48 PD patients with normal cognition (PD-NC), and 33 age- and education-matched healthy controls (HCs), with all participants undergoing neuropsychological assessment and structural magnetic resonance imaging (MRI). Correlation analyses between NBM/Ch4 volume and cortical thickness and correlation coefficient comparisons were conducted within and across groups.

Results: In the PD-MCI group, NBM/Ch4 volume was positively correlated with cortical thickness in the bilateral posterior cingulate, parietal, and frontal and left insular regions. Based on correlation coefficient comparisons, the atrophy of NBM/Ch4 was more correlated with the cortical thickness of right posterior cingulate and precuneus, anterior cingulate and medial orbitofrontal lobe in PD-MCI versus HC, and the right medial orbitofrontal lobe and anterior cingulate in PD-NC versus HC. Further partial correlations between cortical thickness and NBM/Ch4 volume were significant in the right medial orbitofrontal (PD-NC: r=0.3, P=0.045; PD-MCI: r=0.51, P=0.003) and anterior cingulate (PD-NC: r=0.41, P=0.006; PD-MCI: r=0.43, P=0.013) in the PD groups and in the right precuneus (r=0.37, P=0.04) and posterior cingulate (r=0.46, P=0.008) in the PD-MCI group.

Conclusions: The stronger correlation between NBM/Ch4 and cortical thinning in PD-MCI patients suggests that NBM/Ch4 volume loss may play an important role in PD cognitive impairment.

Keywords: Parkinson’s disease (PD); cholinergic system; cognitive impairment; cortical thickness; nucleus basalis of Meynert.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/qims-20-444). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
The regions with significant positive correlation between the volume of the NBM/Ch4 and cortical thickness in PD-MCI patients (correcting for sex, age and duration of disease). (A,B) Lateral aspect; (B,E) medial aspect; (C,F) inferior aspect. The red-orange areas highlight areas of significant positive correlation. The color bar shows the logarithmic scale of P values (-log10).
Figure 2
Figure 2
The regions with significantly stronger correlations between the volume of the NBM/Ch4 and cortical thickness in the comparison of the PD-MCI versus HC groups (left) and the PD-NC versus HC groups (right). (A,D) Medial aspect; (B,E) lateral aspect; (C,E) inferior aspect. The red-orange areas highlight areas of significance. The color bar shows the logarithmic scale of P values (-log10).

Similar articles

Cited by

References

    1. Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord 2015;30:1591-601. 10.1002/mds.26424 - DOI - PubMed
    1. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003;60:387-92. 10.1001/archneur.60.3.387 - DOI - PubMed
    1. Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, Williams-Gray CH, Barker RA, Collerton D, Taylor JP, Burn DJ, ICICLE-PD study group . Cognitive decline and quality of life in incident Parkinson's disease: The role of attention. Parkinsonism Relat Disord 2016;27:47-53. 10.1016/j.parkreldis.2016.04.009 - DOI - PMC - PubMed
    1. Halliday GM, Leverenz JB, Schneider JS, Adler CH. The neurobiological basis of cognitive impairment in Parkinson's disease. Mov Disord 2014;29:634-50. 10.1002/mds.25857 - DOI - PMC - PubMed
    1. Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, Ballard C. Cognitive decline in Parkinson disease. Nat Rev Neurol 2017;13:217-31. 10.1038/nrneurol.2017.27 - DOI - PMC - PubMed

LinkOut - more resources